Log in | Register

Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review

Christian J. Wiedermann| Michael Joannidis
Systematic Review
Volume 40, Issue 2 / February , 2014

Pages 160 - 170

Abstract

Purpose

To systematically review clinical and preclinical data on hydroxyethyl starch (HES) tissue storage.

Methods

MEDLINE (PubMed) was searched and abstracts were screened using defined criteria to identify articles containing original data on HES tissue accumulation.

Results

Forty-eight studies were included: 37 human studies with a total of 635 patients and 11 animal studies. The most frequent indication for fluid infusion was surgery accounting for 282 patients (45.9 %). HES localization in skin was shown by 17 studies, in kidney by 12, in liver by 8, and in bone marrow by 5. Additional sites of HES deposition were lymph nodes, spleen, lung, pancreas, intestine, muscle, trophoblast, and placental stroma. Among major organs the highest measured tissue concentration of HES was in the kidney. HES uptake into intracellular vacuoles was observed by 30 min after infusion. Storage was cumulative, increasing in proportion to dose, although in 15 % of patients storage and associated symptoms were demonstrated at the lowest cumulative doses (0.4 g kg−1). Some HES deposits were extremely long-lasting, persisting for 8 years or more in skin and 10 years in kidney. Pruritus associated with HES storage was described in 17 studies and renal dysfunction in ten studies. In one included randomized trial, HES infusion produced osmotic nephrosis-like lesions indicative of HES storage (p = 0.01) and also increased the need for renal replacement therapy (odds ratio, 9.50; 95 % confidence interval, 1.09–82.7; p = 0.02). The tissue distribution of HES was generally similar in animals and humans.

Conclusions

Tissue storage of HES is widespread, rapid, cumulative, frequently long-lasting, and potentially harmful.

Keywords

References

  1. Bellmann R, Feistritzer C, Wiedermann CJ (2012) Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 51:225–236
    • View reference on PubMed
    • View reference on publisher's website
  2. Thompson WL, Fukushima T, Rutherford RB, Walton RP (1970) Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch. Surg Gynecol Obstet 131:965–972
    • View reference on PubMed
  3. Lindblad G, Falk J (1976) Konzentrationsverlauf von Hydroxyäthylstärke und Dextran in Serum und Lebergewebe von Kaninchen und die histopathologischen Folgen der Speicherung von Hydroxyäthylstärke. Infusionstherapie 3:301–303
  4. Jesch F, Hübner G, Zumtobel V, Zimmermann M, Messmer K (1979) Hydroxyäthylstärke (HÄS 450/0,7) in Plasma und Leber: Konzentrationsverlauf und histologische Veränderungen beim Menschen. Infusionsther Klin Ernahr 6:112–117
    • View reference on PubMed
  5. Pfeifer U, Kult J, Förster H (1984) Ascites als Komplikation hepatischer Speicherung von Hydroxyethylstärke (HES) bei Langzeitdialyse. Klin Wochenschr 62:862–866
    • View reference on PubMed
    • View reference on publisher's website
  6. Dienes HP, Gerharz CD, Wagner R, Weber M, John HD (1986) Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol 3:223–227
    • View reference on PubMed
    • View reference on publisher's website
  7. Sirtl C, Hübner G, Jesch F (1988) Zur Speicherung von hoch-und mittelmolekularer Hydroxyäthylstärke (HÄS) im menshlichen Gewebe. Beitr Anaesth Intensivmed 26:74–97
  8. Sadek S, Owunwanne A, Abdel-Dayem HM, Yacoub T (1989) Preparation and evaluation of Tc-99m hydroxyethyl starch as a potential radiopharmaceutical for lymphoscintigraphy: comparison with Tc-99m human serum albumin, Tc-99m dextran, and Tc-99m sulfur microcolloid. Lymphology 22:157–166
    • View reference on PubMed
  9. Burgstaler EA, Pineda AA (1990) Hydroxyethylstarch as replacement in therapeutic plasma exchange. Prog Clin Biol Res 337:395–397
    • View reference on PubMed
  10. Heilmann L, Lorch E, Hojnacki B, Müntefering H, Förster H (1991) Die Speicherung von zwei unterschiedlichen Hydroxyäthylstärke-Präparaten in der Plazenta nach Hämodilution bei Patientinnen mit fetaler Mangelentwicklung oder Schwangerschaftshochdruck. Infusionstherapie 18:236–243
    • View reference on PubMed
  11. Parth E, Jurecka W, Szépfalusi Z, Schimetta W, Gebhart W, Scheiner O, Kraft D (1992) Histological and immunohistochemical investigations of hydroxyethyl-starch deposits in rat tissues. Eur Surg Res 24:13–21
    • View reference on PubMed
    • View reference on publisher's website
  12. Gall H, Kaufmann R, von Ehr M, Schumann K, Sterry W (1993) Persistierender Pruritus nach Hydroxyäthylstärke-Infusionen: retrospektive Langzeitstudie an 266 Fällen. Hautarzt 44:713–716
    • View reference on PubMed
  13. Hosgood G, Lewis DD, Hodgin EC, Church DF, Lopez MK (1993) Effect of deferoxamine-hydroxyethyl pentafraction starch on free, autogenous full-thickness skin grafts in dogs. Am J Vet Res 54:341–348
    • View reference on PubMed
  14. Jurecka W, Szépfalusi Z, Parth E, Schimetta W, Gebhart W, Scheiner O, Kraft D (1993) Hydroxyethylstarch deposits in human skin—a model for pruritus? Arch Dermatol Res 285:13–19
    • View reference on PubMed
    • View reference on publisher's website
  15. Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248–249
    • View reference on PubMed
    • View reference on publisher's website
  16. Szeimies R-M, Stolz W, Wlotzke U, Korting HC, Landthaler M (1994) Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 131:380–382
    • View reference on PubMed
    • View reference on publisher's website
  17. Leunig A, Szeimies R-M, Wilmes E, Gutmann R, Stolz W, Feyh J (1995) Klinische und elektronenmikroskopische Untersuchung zur Hörsturztherapie mit der Kombination 10% HES 200/0,5 und Pentoxifyllin. Laryngorhinootologie 74:135–140
    • View reference on PubMed
    • View reference on publisher's website
  18. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622
    • View reference on PubMed
    • View reference on publisher's website
  19. Coronel B, Mercatello A, Simone C, Xavier M, Moskovtchenko JF (1996) Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants. Lancet 348:1595
  20. Cox NH, Popple AW (1996) Persistent erythema and pruritus, with a confluent histiocytic skin infiltrate, following the use of a hydroxyethylstarch plasma expander. Br J Dermatol 134:353–357
    • View reference on PubMed
    • View reference on publisher's website
  21. Gall H, Schultz KD, Boehncke WH, Kaufmann R (1996) Clinical and pathophysiological aspects of hydroxyethyl starch-induced pruritus: evaluation of 96 cases. Dermatology 192:222–226
    • View reference on PubMed
    • View reference on publisher's website
  22. Standl T, Lipfert B, Reeker W, Schulte am Esch J, Lorke DE (1996) Akute Auswirkungen eines kompletten Blutaustauschs mit ultragereinigter Hämoglobinlösung oder Hydroxyäthylstärke auf Leber und Niere im Tiermodell. Anästhesiol Intensivmed Notfallmed Schmerzther 31:354–361
    • View reference on PubMed
    • View reference on publisher's website
  23. Speight EL, MacSween RM, Stevens A (1997) Persistent itching due to etherified starch plasma expander. BMJ 314:1466–1467
    • View reference on PubMed
    • View reference on publisher's website
  24. Kiehl P, Metze D, Kresse H, Reimann S, Kraft D, Kapp A (1998) Decreased activity of acid α-glucosidase in a patient with persistent periocular swelling after infusions of hydroxyethyl starch. Br J Dermatol 138:672–677
    • View reference on PubMed
    • View reference on publisher's website
  25. Lukasewitz P, Kroh U, Löwenstein O, Krämer M, Lennartz H (1998) Quantitative Untersuchungen zur Gewebsspeicherung von mittelmolekularer Hydroxyethylstärke 200/0,5 bei Patienten mit Multiorganversagen. J Anaesth Intensivbeh 3:42–46
  26. Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W (1999) Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82:510–515
    • View reference on PubMed
    • View reference on publisher's website
  27. Christidis C, Mal F, Ramos J, Senejoux A, Callard P, Navarro R, Trinchet JC, Larrey D, Beaugrand M, Guettier C (2001) Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 35:726–732
    • View reference on PubMed
    • View reference on publisher's website
  28. de Labarthe A, Jacobs F, Blot F, Glotz D (2001) Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111:417–418
    • View reference on PubMed
    • View reference on publisher's website
  29. Ständer S, Szépfalusi Z, Bohle B, Ständer H, Kraft D, Luger TA, Metze D (2001) Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study. Cell Tissue Res 304:261–269
    • View reference on PubMed
    • View reference on publisher's website
  30. Ständer S, Bone HG, Machens HG, Aberle T, Burchard W, Prien T, Luger TA, Metze D (2002) Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals. Cell Tissue Res 310:279–287
    • View reference on PubMed
    • View reference on publisher's website
  31. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F (2003) Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 4:331–338
    • View reference on PubMed
    • View reference on publisher's website
  32. Weisshaar E, Ständer S, Metze D, Diepgen TL (2004) Hydroxyethylstärke- (HES-)induzierter Pruritus als sekundäre Folge eines Arbeitsunfalls. Hautarzt 55:558–561
    • View reference on PubMed
    • View reference on publisher's website
  33. Pillebout E, Nochy D, Hill G, Conti F, Antoine C, Calmus Y, Glotz D (2005) Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 5:1120–1129
    • View reference on PubMed
    • View reference on publisher's website
  34. Ständer S, Evers S, Metze D, Schmelz M (2005) Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibres. Br J Dermatol 152:1085–1086
    • View reference on PubMed
    • View reference on publisher's website
  35. Auwerda JJ, Leebeek FW, Wilson JH, van Diggelen OP, Lam KH, Sonneveld P (2006) Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 46:1705–1711
    • View reference on PubMed
    • View reference on publisher's website
  36. Ebcioglu Z, Cohen DJ, Crew RJ, Hardy MA, Ratner LE, D’Agati VD, Markowitz GS (2006) Osmotic nephrosis in a renal transplant recipient. Kidney Int 70:1873–1876
    • View reference on PubMed
    • View reference on publisher's website
  37. Schmidt-Hieber M, Loddenkemper C, Schwartz S, Arntz G, Thiel E, Notter M (2006) Hydrops lysosomalis generalisatus—an underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol 77:83–85
    • View reference on PubMed
    • View reference on publisher's website
  38. Eisenbach C, Schönfeld AH, Vogt N, Wente MN, Encke J, Stremmel W, Martin E, Pfenninger E, Weigand MA (2007) Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution. Intensive Care Med 33:1637–1644
  39. Kamann S, Flaig MJ, Korting HC (2007) Hydroxyethyl starch-induced itch: relevance of light microscopic analysis of semi-thin sections and electron microscopy. J Dtsch Dermatol Ges 5:204–208
    • View reference on PubMed
    • View reference on publisher's website
  40. Chappell D, Bruchelt W, Schenk W, Jacob M, Hofmann-Kiefer K, Conzen P, Kreimeier U, Rehm M (2008) Development of spontaneous subdural hematoma and bone marrow depression after hydroxyethyl starch administration. J Pediatr 153:579–581
    • View reference on PubMed
    • View reference on publisher's website
  41. Haught JM, Jukic DM, English JC 3rd (2008) Hydroxyethyl starch-induced pruritus relieved by a combination of menthol and camphor. J Am Acad Dermatol 59:151–153
    • View reference on PubMed
    • View reference on publisher's website
  42. Jamal R, Ghannoum M, Naud J-F, Turgeon P-P, Leblanc M (2008) Permanent renal failure induced by pentastarch. NDT Plus 5:322–325
    • View reference on publisher's website
  43. Brandt S, Regueira T, Bracht H, Porta F, Djafarzadeh S, Takala J, Gorrasi J, Borotto E, Krejci V, Hiltebrand LB, Bruegger LE, Beldi G, Wilkens L, Lepper PM, Kessler U, Jakob SM (2009) Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit Care 13:R186
    • View reference on PubMed
    • View reference on publisher's website
  44. Hagne C, Schwarz A, Gaspert A, Giambarba C, Keusch G (2009) HAES in der Sepsis: ein Damoklesschwert? Schweiz Med Forum 9:304–306
  45. Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G (2009) Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 13:R23
    • View reference on PubMed
    • View reference on publisher's website
  46. Zhao HJ, Chen HP, Meng ZY, Wang Q (2009) A case of acute renal failure due to hydroxyethyl starch. Clin Nephrol 71:329–332
    • View reference on PubMed
    • View reference on publisher's website
  47. Aneja S, Sood A, Taylor JS, McMahon JT, Billings SD, Bergfeld WF (2012) Generalized pruritus sine materia precipitated by exposure to hydroxyethyl starch. J Am Acad Dermatol 66:AB53
    • View reference on publisher's website
  48. Kumar AB, Suneja M (2012) Hetastarch-induced osmotic nephrosis. Anesthesiology 117:647
    • View reference on PubMed
    • View reference on publisher's website
  49. Ständer S, Richter L, Osada N, Metze D (2013) Hydroxyethyl starch-induced pruritus: clinical characteristics and influence of dose, molecular weight and substitution. Acta Derm Venereol. doi:10.2340/00015555-1639
  50. Metze D, Reimann S, Szépfalusi Z, Bohle B, Kraft D, Luger TA (1997) Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol 136:553–559
    • View reference on PubMed
    • View reference on publisher's website
  51. Reimann S, Szépfalusi Z, Kraft D, Luger T, Metze D (2000) Hydroxyethylstärke-Speicherung in der Haut unter besonderer Berücksichtigung des Hydroxyethylstärke-assoziierten Juckreizes. Dtsch Med Wochenschr 125:280–285
    • View reference on PubMed
    • View reference on publisher's website
  52. Auwerda JJ, Wilson JH, Sonneveld P (2002) Foamy macrophage syndrome due to hydroxyethyl starch replacement: a severe side effect in plasmapheresis. Ann Intern Med 137:1013–1014
    • View reference on PubMed
    • View reference on publisher's website
  53. Bork K (2005) Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 152:3–12
    • View reference on PubMed
    • View reference on publisher's website
  54. Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD007594
    • View reference on PubMed
  55. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S, CHEST Management Committee (2013) Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 39:558–568
  56. Dickenmann M, Oettl T, Mihatsch MJ (2008) Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51:491–503
    • View reference on PubMed
    • View reference on publisher's website
  57. Ferber HP, Nitsch E, Förster H (1985) Studies on hydroxyethyl starch. Part II: changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers. Arzneimittelforschung 35:615–622
    • View reference on PubMed
  58. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367:1901–1911
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement